NEWS

Press Release
Source: Versar, Inc.

Versar Awarded Biological Laboratory Project in Texas

Wednesday October 15, 9:20 am ET SPRINGFIELD, Va., Oct. 15 /PRNewswire-FirstCall/ --

VERSAR, Inc. (Amex: VSR - News) announced today that it has been awarded a task order valued at approximately $750,000 from the U.S. Air Force for the construction of an Epidemic Outbreak Surveillance Advanced Diagnostics Laboratory at Lackland Air Force Base, Texas. The laboratory will support the Air Force Surgeon General and Lackland AFB by utilizing advanced diagnostics for real- time identification for both common pathogens and bio-warfare agents. Completion date is June 30, 2004.

The Air Force Center for Environmental Excellence (AFCEE) in San Antonio, Texas awarded Versar the task order under its Environmental Restoration and Construction Contract ("ENRAC"). The Company previously announced its master ENRAC award on May 22, 2001. The contract will continue to provide environmental remediation and construction activities at Air Force and other Federal installations.

Versar's President and CEO, Dr. Ted Prociv, said, "This award demonstrates Versar's continuing commitment to innovation in bio-warfare defense, and to our Air Force customers. Defense against terrorist threats represents a growing part of Versar's business."

Versar, Inc., headquartered in Springfield, VA, is a publicly held professional services firm supporting government and industry in national defense/homeland defense programs, environmental health and safety and infrastructure revitalization. Versar operates a number of web sites, including the corporate Web sites, http://www.versar.com, http://www.homelanddefense.com, and http://www.geomet.com; and a B2B portal for homeland defense products and services, http://www.nbcprotect.com.

This press release contains forward-looking information. The forward- looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar's Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended June 30, 2003.

Investor Relations Contact: Andrew J. Kaplan (732) 747-0702
Barry Kaplan Associates
623 River Road Fair Haven, NJ 07704